|
|
|
|
Abbott reports flat 4th-quarter profit on 11% higher sales
BOSTON (MarketWatch) -- Abbott Laboratories reported that its fourth-quarter profit was virtually flat with that of the year-earlier quarter, due largely to various accounting charges./quotes/comstock/13*!abt/quotes/nls/abt ABT 54.26, +0.36, +0.67% Before...
|
|
|
On the Call: Abbott Laboratories
Abbott Laboratories profit stays flat in 4Q Abbott Laboratories said Wednesday its fourth-quarter profit was flat on higher costs, but sales of the company's diverse mix of drugs, devices and nutritional formula continued to drive revenue.Abbott management...
|
|
|
Abbott bullish over 2010 earnings growth
Abbott Laboratories reports double-digit sales and earnings growth in fourth quarter.And it has issued a strong earnings outlook for 2010. Worldwide sales increased 10.6% to nearly $8.8bn, including a favourable 2.4% effect of exchange rates. Excluding...
|
|
|
Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Issues Strong Earnings Outlook for 2010
ABBOTT PARK, Ill., Jan.27 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced financial results for the fourth quarter ended Dec. 31, 2009. Diluted earnings per share, excluding specified items, were $1.18, reflecting 11.3 percent growth, at the...
|
|
|
Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Issues Strong Earnings Outlook for 20
- Worldwide Sales Increased 10.6 Percent - - Adjusted EPS Growth of 11.3 Percent (GAAP EPS Growth of 10.1 Percent) - - Worldwide Medical Products Sales Increased 23.4 Percent - - International Nutritional Sales Increased 11.0 Percent - - International...
|
|
|
Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Issues Strong Earnings Outlook for 2010
- Worldwide Sales Increased 10.6 Percent - - Adjusted EPS Growth of 11.3 Percent (GAAP EPS Growth of 10.1 Percent) - - Worldwide Medical Products Sales Increased 23.4 Percent - - International Nutritional Sales Increased 11.0 Percent - - International...
|
|
|
Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Issues Strong Earnings Outlook for 2010
- Worldwide Sales Increased 10.6 Percent - - Adjusted EPS Growth of 11.3 Percent (GAAP EPS Growth of 10.1 Percent) - - Worldwide Medical Products Sales Increased 23.4 Percent - - International Nutritional Sales Increased 11.0 Percent - - International...
|
|
|
Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Issues Strong Earnings Outlook for 2010
- Worldwide Sales Increased 10.6 Percent - - Adjusted EPS Growth of 11.3 Percent (GAAP EPS Growth of 10.1 Percent) - - Worldwide Medical Products Sales Increased 23.4 Percent - - International Nutritional Sales Increased 11.0 Percent - - International...
|
|
|
Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Issues Strong Earnings Outlook for 2010
- Worldwide Sales Increased 10.6 Percent - - Adjusted EPS Growth of 11.3 Percent (GAAP EPS Growth of 10.1 Percent) - - Worldwide Medical Products Sales Increased 23.4 Percent - - International Nutritional Sales Increased 11.0 Percent - - International...
|
|
|
Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Issues Strong Earnings Outlook for 2010
- Worldwide Sales Increased 10.6 Percent - - Adjusted EPS Growth of 11.3 Percent (GAAP EPS Growth of 10.1 Percent) - - Worldwide Medical Products Sales Increased 23.4 Percent - - International Nutritional Sales Increased 11.0 Percent - - International...
|
|
|
Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Issues Strong Earnings Outlook for 2010
- Worldwide Sales Increased 10.6 Percent - - Adjusted EPS Growth of 11.3 Percent (GAAP EPS Growth of 10.1 Percent) - - Worldwide Medical Products Sales Increased 23.4 Percent - - International Nutritional Sales Increased 11.0 Percent - - International...
|
|
|
Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Issues Strong Earnings Outlook for 2010
- Worldwide Sales Increased 10.6 Percent - - Adjusted EPS Growth of 11.3 Percent (GAAP EPS Growth of 10.1 Percent) - - Worldwide Medical Products Sales Increased 23.4 Percent - - International Nutritional Sales Increased 11.0 Percent - - International...
|
|
|
Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Issues Strong Earnings Outlook for 2010
- Worldwide Sales Increased 10.6 Percent - - Adjusted EPS Growth of 11.3 Percent (GAAP EPS Growth of 10.1 Percent) - - Worldwide Medical Products Sales Increased 23.4 Percent - - International Nutritional Sales Increased 11.0 Percent - - International...
|
|
|
Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Issues Strong Earnings Outlook for 2010
- Worldwide Sales Increased 10.6 Percent - - Adjusted EPS Growth of 11.3 Percent (GAAP EPS Growth of 10.1 Percent) - - Worldwide Medical Products Sales Increased 23.4 Percent - - International Nutritional Sales Increased 11.0 Percent - - International...
|
|
|
Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Issues Strong Earnings Outlook for 2010
- Worldwide Sales Increased 10.6 Percent - - Adjusted EPS Growth of 11.3 Percent (GAAP EPS Growth of 10.1 Percent) - - Worldwide Medical Products Sales Increased 23.4 Percent - - International Nutritional Sales Increased 11.0 Percent - - International...
|
|
|
Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Issues Strong Earnings Outlook for 2010
- Worldwide Sales Increased 10.6 Percent - - Adjusted EPS Growth of 11.3 Percent (GAAP EPS Growth of 10.1 Percent) - - Worldwide Medical Products Sales Increased 23.4 Percent - - International Nutritional Sales Increased 11.0 Percent - - International...
|
|
|
Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Issues Strong Earnings Outlook for 2010
- Worldwide Sales Increased 10.6 Percent - - Adjusted EPS Growth of 11.3 Percent (GAAP EPS Growth of 10.1 Percent) - - Worldwide Medical Products Sales Increased 23.4 Percent - - International Nutritional Sales Increased 11.0 Percent - - International...
|
|
|
Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Issues Strong Earnings Outlook for 2010
- Worldwide Sales Increased 10.6 Percent - - Adjusted EPS Growth of 11.3 Percent (GAAP EPS Growth of 10.1 Percent) - - Worldwide Medical Products Sales Increased 23.4 Percent - - International Nutritional Sales Increased 11.0 Percent - - International...
|
|
|
Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Issues Strong Earnings Outlook for 2010
- Worldwide Sales Increased 10.6 Percent - - Adjusted EPS Growth of 11.3 Percent (GAAP EPS Growth of 10.1 Percent) - - Worldwide Medical Products Sales Increased 23.4 Percent - - International Nutritional Sales Increased 11.0 Percent - - International...
|
|
|
Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Issues Strong Earnings Outlook for 2010
- Worldwide Sales Increased 10.6 Percent - - Adjusted EPS Growth of 11.3 Percent (GAAP EPS Growth of 10.1 Percent) - - Worldwide Medical Products Sales Increased 23.4 Percent - - International Nutritional Sales Increased 11.0 Percent - - International...
|
|
|
Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Issues Strong Earnings Outlook for 2010
ABBOTT PARK, Ill., Jan.27 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced financial results for the fourth quarter ended Dec. 31, 2009. -- Diluted earnings per share, excluding specified items, were $1.18, reflecting 11.3 percent growth, at...
|
|
|
Abbott Reports Double-Digit Sales and Earnings Growth in Fourth
Worldwide Sales Increased 10.6 Percent -- Adjusted EPS Growth of 11.3 Percent (GAAP EPS Growth of 10.1 Percent) -- Worldwide Medical Products Sales Increased 23.4 Percent -- International Nutritional Sales Increased 11.0 Percent -- International Pharmaceutical...
|
|
|
Abbott bipolar drug sales down in flat 4Q
Abbott Laboratories this morning reported flat fourth-quarter earnings amid the global economic downturn and increased generic competition to its once blockbuster bipolar and epilepsy treatment Depakote.The North Chicago drug and medical product giant...
|
|
|
Abbott 4Q flat with diet, bipolar drug sales down
Abbott Laboratories this morning reported flat fourth-quarter earnings amid the global economic downturn and increased generic competition to its once blockbuster bipolar and epilepsy treatment Depakote.The North Chicago drug and medical product giant...
|
|
|
Abbott profit little changed as costs offset sales
NEW YORK -- Abbott Laboratories said Wednesday its fourth-quarter profit was flat on higher costs, but sales of the company's diverse mix of drugs, devices and nutritional formula continued to drive revenue.Abbott management set higher earnings guidance for...
|
